Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection

Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

Frontiers in pharmacology·2026

Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

Frontiers in pharmacology·2026

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Journal of molecular medicine (Berlin, Germany)·2020

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA).

Scientific reports·2019

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

HIV medicine·2019

Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial.

International journal of cardiology·2019

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Journal of hepatology·2026

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Journal of hepatology·2026

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Journal of hepatology·2026

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

Journal of hepatology·2026

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Journal of hepatology·2026

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Journal of hepatology·2026

Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

Journal of human immunity·2026

A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026

Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

Recent advances in drug delivery and formulation·2026

Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

Omics : a journal of integrative biology·2026

Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

International journal of molecular medicine·2026

Jejunal Leiomyoma Arising in a Diverticulum Mimicking a Hollow Viscus Perforation: A Diagnostic Challenge.

Cureus·2026

Related Experiment Videos

Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection

Related Concept Videos

Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA).

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial.

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

Jejunal Leiomyoma Arising in a Diverticulum Mimicking a Hollow Viscus Perforation: A Diagnostic Challenge.

Related Experiment Videos

Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection

Related Concept Videos

Related Articles